Griswold, D E <br/><br/>
Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response.  [electronic resource] 

 -  Inflammation  Jun 1993 
 - 333-44 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article 
<br/><br/><label>ISSN: </label>0360-3997 
<br/><br/><label>Standard No.: </label>10.1007/BF00918994  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3',5'-Cyclic-AMP Phosphodiesterases<br/>Animals<br/>Anti-Inflammatory Agents, Non-Steroidal--pharmacology<br/>Arachidonic Acid--toxicity<br/>Calcimycin--pharmacology<br/>Cells, Cultured<br/>Colforsin--pharmacology<br/>Cyclic Nucleotide Phosphodiesterases, Type 4<br/>Ear, External<br/>Eicosanoids--metabolism<br/>Histamine Release--drug effects<br/>Humans<br/>Imidazoles--pharmacology<br/>Inflammation--chemically induced<br/>Leukotriene B4--biosynthesis<br/>Male<br/>Mast Cells--drug effects<br/>Mice<br/>Mice, Inbred BALB C<br/>Monocytes--drug effects<br/>Nadolol--pharmacology<br/>Naproxen--pharmacology<br/>Neutrophils--drug effects<br/>Phosphodiesterase Inhibitors--pharmacology<br/>Phosphoric Diester Hydrolases--physiology<br/>Purinones--pharmacology<br/>Pyrazoles--pharmacology<br/>Pyrrolidinones--pharmacology<br/>Receptors, Adrenergic, beta--drug effects<br/>Rolipram<br/>SRS-A--metabolism<br/>Thiazoles--pharmacology